News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Xiaoling Zhang

Articles by Xiaoling Zhang

TPS 38 ELCIN: Elacestrant in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer: An Open-Label, Multicenter, Phase 2 Study

ByVirginia Kaklamani, MD, DSc,Giorgi Dzagnidze,Nicoleta Zenovia Antone,Anu Thummala,Mikheil Janjalia,Patricia Santi,Carlos Barrios,Mehmet Ali Nahit Sendur,Xiaoling Zhang,Angela Gambioli,Manuel Dominguez,Kathy Puyana Theall,Tomer Wasserman,William J. Gradishar, MD

June 12th 2025

Latest Updated Articles

Trending on CancerNetwork

177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC

H.R. 2541: Examining Its Legislative Impact on Radiopharmaceutical Practice

Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC

FDA Grants Iopofosine I 131 Rare Pediatric Drug Designation in R/R Glioma

© 2025 MJH Life Sciences^®

All rights reserved.